Two milestones reached today for PROTECT-V Clinical Trial. First patient recruited this morning at King's College NHS - congratulations! And the 100th patient recruited into the study this afternoon Cambridge University Hospitals NHS 🎉🎉🎉🎉🎉Kidney Research UK NIHR Cambridge Biomedical Research Centre Addenbrooke's Charity

A clinical trial, initially funded by Kidney Research UK, to find out whether a drug usually used to treat tapeworms can prevent Covid-19 infection in vulnerable kidney patients has expanded into India in an exciting new development. Read more below 👇 bit.ly/3Nn62Gv

Great news to get the first patient recruited to the Sotrovimab prophylactic monoclonal arm of Protect-V and screening bloods smoothly through our lab 💪Immunology and Immunotherapy UHBRespResearch @Dr_D_Dosanjh

#NewYearHonours congratulations John Mills MBE - from us all at #VasculitisUK for supporting all those diagnosed with #vasculitis a #RareDisease , for the past 13 years. 👏

Rona Smith. COI trial physician for RITAZAREM trial. New to NephJC! #NephJC

The second meeting between RSM Nephrology and Kidney Research UK Glomerulonephritis (GN) Clinical Study Group (CSG) will update on advancements in basic science, therapeutic targets, and clinical trials in glomerulonephritis. Thursday 21 September 👇 bit.ly/43L9cMt

Join this collaboration between RSM #Nephrology and Kidney Research UK's Glomerulonephritis Clinical Study Group, showcasing developments in the field of inflammatory renal disease. Wednesday 20 September at the RSM 👇 rsm.ac/43ehaxp

There's a LOT going on in the rare community, so we've extended this survey until 24 Sept! If you're affected by a #RareDisease, consider sharing your thoughts on research design & help shape a new community-led research platform! Cambridge Rare Disease Network (CamRARE) Beacon for Rare Diseases Genetic Alliance UK